Can a pill and a vaccine stop STIs in High-Risk men?

NCT ID NCT04597424

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two strategies to prevent sexually transmitted infections (STIs) in men who have sex with men and already take HIV PrEP. One group took doxycycline pills after unprotected sex, and another group received a meningitis vaccine (Bexsero). The goal was to see if these approaches could reduce new cases of chlamydia, syphilis, and gonorrhea. Over 550 men took part in this completed Phase 3 trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
doxycycline and Bexsero® vaccine
What this could lead to
If it works, this could offer a new way to prevent bacterial STIs in high-risk groups, reducing infections like chlamydia, syphilis, and gonorrhea.
What could go wrong
This is a completed Phase 3 trial, but results may not apply to all populations. Doxycycline overuse could lead to antibiotic resistance, and the vaccine may not protect against all gonorrhea strains.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL SEXUALLY TRANSMITTED INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Bichat

    Paris, 75000, France

  • Hôpital Européen Georges Pompidou

    Paris, 75908, France

  • Hôpital Hôtel Dieu

    Paris, 75181, France

  • Hôpital Necker-Enfants Malades

    Paris, 75743, France

  • Hôpital Pitié-Salpétrière

    Paris, 75651, France

  • Hôpital Saint-Antoine

    Paris, 75571, France

  • Hôpital Saint-Louis

    Paris, 75475, France

  • Hôpital Tenon

    Paris, 75970, France

  • Hôpital pitié Salpetrière

    Paris, 75651, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.